Cancer Research

The engineering of autologous T-cells to express receptors for the Kappa Myeloma Antigen offers a precision-guided approach to treating the second most common blood cancer worldwide. This milestone has been realized through the commencement of the Phase 1 KOALA study, a first-in-human clinical

The SLICeVLP system decouples guide RNA delivery from Cas9 protein delivery to enable large-scale pooled CRISPR screening in primary human macrophages for the first time. This technological leap addresses a longstanding bottleneck in the field of immunotherapy, where the focus has historically

The shift toward precision medicine requires a continuous assessment of risk that updates dynamically as new follow-up scans and blood tests become available. This ongoing demand for agility is driving a fundamental transformation in lung cancer management, moving the field away from isolated

In addition to the recent NCI renewal, the UC Davis Medical Center has maintained its ranking as the top hospital in the Sacramento area for fifteen consecutive years according to national reports. This sustained excellence reached a new milestone today as the National Cancer Institute officially

When levels of miR-342 drop, the E2F genetic pathway is unleashed, signaling disseminated cancer cells to begin the rapid multiplication required to form tumors. This mechanism serves as a terrifying catalyst for triple-negative breast cancer, a subtype that has historically defied the precision

A strategic partnership with a pharmaceutical firm allows Outer Biosciences to investigate the biological mechanisms behind skin rashes caused by cancer treatments. This initiative marks a significant departure from traditional dermatological research, signaling a move toward high-precision,